Cleared Traditional

K112682 - METHA HIP SYSTEM

K112682 is an FDA 510(k) clearance for METHA HIP SYSTEM, manufactured by Aesculap Implant Systems, LLC. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 186-day FDA review.

K112682 · Aesculap Implant Systems, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2012
Decision
186d
Days
Class 2
Risk

K112682 is an FDA 510(k) clearance for the METHA HIP SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Aesculap Implant Systems, LLC (Center Valley, US). The FDA issued a Cleared decision on March 19, 2012 after a review of 186 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Aesculap Implant Systems, LLC devices

FDA 510(k) Submission Details - K112682

510(k) Number K112682 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2011
Decision Date March 19, 2012
Days to Decision 186 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 122d · This submission: 186d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 454
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K112682.
AMISTEM AND QUADRA - LINE EXTENSION
K121011 · Medacta International · Jun 2012
METAFIX FEMORAL STEM FOR HEMI-ARTHROPLASTY
K120362 · Corin USA · May 2012
VERSAFITCUP CC TRIO-ADDITIONAL LINERS
K120531 · Medacta International · Apr 2012
WAGNER CONE PROSTHESIS SYSTEM
K113556 · Zimmer GmbH · Feb 2012
MECTACER BIOLOX(R) DELTA FEMORAL HEADS
K112115 · Medacta International · Oct 2011
UNITED 36MM CERAMIC FEMORAL HEAD, DELTA
K112463 · United Orthopedic Corporation · Sep 2011